Cargando…
What do people with type 2 diabetes want from a brief messaging system to support medication adherence?
BACKGROUND: Many people with type 2 diabetes do not take their treatment as prescribed. Brief messages to support medication use could reach large numbers of people at a very low cost per person, but current interventions using brief messages rarely adequately describe the content of the messages, n...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777899/ https://www.ncbi.nlm.nih.gov/pubmed/31686789 http://dx.doi.org/10.2147/PPA.S217843 |
_version_ | 1783456681544384512 |
---|---|
author | Bartlett, Yvonne Kiera Newhouse, Nikki Long, Hannah A Farmer, Andrew J French, David P |
author_facet | Bartlett, Yvonne Kiera Newhouse, Nikki Long, Hannah A Farmer, Andrew J French, David P |
author_sort | Bartlett, Yvonne Kiera |
collection | PubMed |
description | BACKGROUND: Many people with type 2 diabetes do not take their treatment as prescribed. Brief messages to support medication use could reach large numbers of people at a very low cost per person, but current interventions using brief messages rarely adequately describe the content of the messages, nor base these messages on explicit behavior change principles. This study reports the views of people with type 2 diabetes concerning the acceptability of 1) a messaging system and 2) proposed messages based on behavior change techniques (BCTs) and beliefs and concerns around taking medication. METHODS: The proposed system and brief messages were discussed in focus groups of people with type 2 diabetes recruited through general practices in England. Transcripts were analyzed thematically. PARTICIPANTS: Twenty-three participants took part in one of five focus group discussions. All participants were over 18 years, were taking tablet medication for their diabetes, and had access to a mobile phone. Key exclusion criteria were recent hospitalization for hyper- or hypoglycemia or diagnosis with a terminal illness. RESULTS: Four themes were identified as relating to the acceptability of the messaging system: “opportunities and limitations of technology”, “us and them (who is the system for?)”, “responsibility for adherence”, and “diabetes management beyond medication”. Participants recognized the benefit of using technology. Those with high confidence in their ability to adhere were keen to make a distinction between themselves and those who did not adhere; participants were more comfortable taking responsibility for medication than diet and exercise. Acceptability of the messages hinged on avoiding “preaching to the converted”. CONCLUSIONS: These findings show that brief messaging could be acceptable to the target population for a range of diabetes-related behaviors but highlight the need for such a system to be perceived as personally relevant. Acceptable messages would need to maintain novelty for the target population. |
format | Online Article Text |
id | pubmed-6777899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-67778992019-11-04 What do people with type 2 diabetes want from a brief messaging system to support medication adherence? Bartlett, Yvonne Kiera Newhouse, Nikki Long, Hannah A Farmer, Andrew J French, David P Patient Prefer Adherence Original Research BACKGROUND: Many people with type 2 diabetes do not take their treatment as prescribed. Brief messages to support medication use could reach large numbers of people at a very low cost per person, but current interventions using brief messages rarely adequately describe the content of the messages, nor base these messages on explicit behavior change principles. This study reports the views of people with type 2 diabetes concerning the acceptability of 1) a messaging system and 2) proposed messages based on behavior change techniques (BCTs) and beliefs and concerns around taking medication. METHODS: The proposed system and brief messages were discussed in focus groups of people with type 2 diabetes recruited through general practices in England. Transcripts were analyzed thematically. PARTICIPANTS: Twenty-three participants took part in one of five focus group discussions. All participants were over 18 years, were taking tablet medication for their diabetes, and had access to a mobile phone. Key exclusion criteria were recent hospitalization for hyper- or hypoglycemia or diagnosis with a terminal illness. RESULTS: Four themes were identified as relating to the acceptability of the messaging system: “opportunities and limitations of technology”, “us and them (who is the system for?)”, “responsibility for adherence”, and “diabetes management beyond medication”. Participants recognized the benefit of using technology. Those with high confidence in their ability to adhere were keen to make a distinction between themselves and those who did not adhere; participants were more comfortable taking responsibility for medication than diet and exercise. Acceptability of the messages hinged on avoiding “preaching to the converted”. CONCLUSIONS: These findings show that brief messaging could be acceptable to the target population for a range of diabetes-related behaviors but highlight the need for such a system to be perceived as personally relevant. Acceptable messages would need to maintain novelty for the target population. Dove 2019-09-30 /pmc/articles/PMC6777899/ /pubmed/31686789 http://dx.doi.org/10.2147/PPA.S217843 Text en © 2019 Bartlett et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Bartlett, Yvonne Kiera Newhouse, Nikki Long, Hannah A Farmer, Andrew J French, David P What do people with type 2 diabetes want from a brief messaging system to support medication adherence? |
title | What do people with type 2 diabetes want from a brief messaging system to support medication adherence? |
title_full | What do people with type 2 diabetes want from a brief messaging system to support medication adherence? |
title_fullStr | What do people with type 2 diabetes want from a brief messaging system to support medication adherence? |
title_full_unstemmed | What do people with type 2 diabetes want from a brief messaging system to support medication adherence? |
title_short | What do people with type 2 diabetes want from a brief messaging system to support medication adherence? |
title_sort | what do people with type 2 diabetes want from a brief messaging system to support medication adherence? |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777899/ https://www.ncbi.nlm.nih.gov/pubmed/31686789 http://dx.doi.org/10.2147/PPA.S217843 |
work_keys_str_mv | AT bartlettyvonnekiera whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence AT newhousenikki whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence AT longhannaha whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence AT farmerandrewj whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence AT frenchdavidp whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence |